Glycinebetaine

Glycinebetaine

SCHEMBL618945

C[N+](C)(C)CC(=O)[O-].NCC(=O)O.O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

BHMTBHMT2

The experimentally established mechanism targets of Glycinebetaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
APEX1 P27695 1/20 0.48
GLRA1 P23415 1/20 0.46
SLC6A9 P48067 1/20 0.46
OR51E2 Q9H255 1/20 0.46
CPT2 P23786 1/20 0.38
CPT1A P50416 1/20 0.38
SLC22A16 Q86VW1 1/20 0.35
BBOX1 O75936 4/20 0.31
MAPT P10636 1/20 0.31
GABRR1 P24046 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycinebetaine SCHEMBL75899 0.98 TSHR (0.52) TSHRALDH1A1LMNAAPEX1GLRA1
Glycinebetaine SCHEMBL18301505 0.95 TSHR (0.50) TSHRALDH1A1LMNAAPEX1GLRA1
Glycinebetaine SCHEMBL21084282 0.88 TSHR (0.43) TSHRALDH1A1LMNAAPEX1GLRA1
Glycinebetaine SCHEMBL285287 0.85
Glycinebetaine SCHEMBL4457941 0.85 TSHR (0.50) TSHRALDH1A1LMNAAPEX1CPT2
Glycinebetaine SCHEMBL4541516 0.85 TSHR (0.40) TSHRALDH1A1LMNAAPEX1GLRA1
Glycinebetaine SCHEMBL20298304 0.85 TSHR (0.40) TSHRALDH1A1LMNAAPEX1GLRA1
Glycinebetaine SCHEMBL6673018 0.83 TSHR (0.50) TSHRALDH1A1LMNAAPEX1CPT2
Glycinebetaine SCHEMBL7521843 0.83 TSHR (0.43) TSHRALDH1A1LMNAAPEX1CPT2
Glycinebetaine SCHEMBL13733441 0.83 TSHR (0.50) TSHRALDH1A1LMNAAPEX1OR51E2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108633288-A thermostable β -glucuronidase preparations 综合微色谱系统有限责任公司 2018-10-09 CN claimed
US-20100330174-A1 BETAINE COMPOSITIONS BIO ETHIC SPRL. (BE) 2010-12-30 US claimed
EP-1569692-B1 Betaine and salicylic acid compositions MESSADEK JALLAL (BE) 2010-11-10 EP claimed
US-7780990-B2 Combination therapeutic compositions and method of use MESSADEK JALLAL 2010-08-24 US claimed
US-20080031964-A1 COMBINATION THERAPEUTIC COMPOSITIONS AND METHOD OF USE MESSADEK JALLAL 2008-02-07 US claimed
US-20060233877-A1 Betaine compositions BIO ETHIC SPRL. (BE) 2006-10-19 US claimed
EP-1569692-A2 BETAINE AND SALICYLIC ACID COMPOSITIONS Messadek, Jallal (BE) 2005-09-07 EP claimed
WO-2004049095-A2 BETAINE AND SALICYLIC ACID COMPOSITIONS MESSADEK JALLAL (BE) 2004-06-10 WO claimed
CN-104936977-B Microtubule-modifying compounds 开普敦大学 2019-10-08 CN disclosed
CN-109789063-A Personal Care Gels and Methods 高露洁-棕榄公司 2019-05-21 CN disclosed
CN-109645110-A Non- gel-type easy cleaning wax fruit composite preservative and preparation method thereof 山东祥维斯生物科技股份有限公司 2019-04-19 CN disclosed
CN-109527221-A Saccharomycete base compound micro-ecological preparation containing Valine and preparation method thereof 吕锋 2019-03-29 CN disclosed
CN-109476872-A Material suit 惠普发展公司,有限责任合伙企业 2019-03-15 CN disclosed
CN-108633288-A thermostable β -glucuronidase preparations 综合微色谱系统有限责任公司 2018-10-09 CN disclosed
US-20060128657-A1 Selected betaines and their uses MESSADEK JALLAL 2006-06-15 US disclosed
EP-1660070-A2 SELECTED BETAINES AND THEIR USES Messadek, Jallal (BE) 2006-05-31 EP disclosed
WO-2006007671-A2 THERAPEUTICALLY COMBINATIONS MESSADEK JALLAL (BE) 2006-01-26 WO disclosed
EP-1569692-A2 BETAINE AND SALICYLIC ACID COMPOSITIONS Messadek, Jallal (BE) 2005-09-07 EP disclosed
WO-2005011645-A2 SELECTED BETAINES AND THEIR USES MESSADEK JALLAL (BE) 2005-02-10 WO disclosed
WO-2004049095-A2 BETAINE AND SALICYLIC ACID COMPOSITIONS MESSADEK JALLAL (BE) 2004-06-10 WO disclosed